FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...
Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G (Rule 13d-102) Information to...
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-268082 PROSPECTUS...
Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced...
false 0001531978 0001531978 2023-01-25 2023-01-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
false000153197800015319782023-01-102023-01-10 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549 ...
Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.